Viva Ma, PhD

Dr. Ma is the Director of Strategic Access, Greater Asia, in Becton Dickinson (BD), one of the largest global medical device companies. Prior to BD, she worked at Johnson & Johnson and Edwards Lifesciences in several corporate functions including health economics, market access, reimbursement and supply chain. Dr. Ma has dedicated her career to improving the affordability and patient access to innovative diagnostic and therapeutic technologies around the world. As an Executive Committee member for the International Society for Pharmacoeconomics Outcomes Research (ISPOR) Singapore, she is a catalyst in building the health economics and outcomes research capacity for the Asia Pacific region, working closely with research institutions Through her leadership role in HTAi Asia Policy Forum and AmCham Singapore, she is actively driving value-based healthcare, as well as cross-sector dialogues and partnerships in the healthcare eco-system. Dr. Ma is an Editorial Board member of the journal Clinical Diabetes, Frontiers in Endocrinology.

Education

• MPH, Johns Hopkins University Bloomberg School of Public Health
• MBA, Johns Hopkins University Carey Business School
• PhD, University of Wyoming
• Postdoctoral, Yale University School of Medicine

Research

Selected publications

• Chua B, Ma V, Asjes C, Lim A, Mohseni M, Wee HL. Barriers to and Facilitators of Cervical Cancer Screening among Women in Southeast Asia: A Systematic Review. International Journal of Environmental Research and Public Health. 2021;18(9):4586.
• Ma Y, M Guess, A Datar, A Hennessey, I Cardenas, J Johnson, and KA Connell. Knockdown of Hoxa11 in vivo in the uterosacral ligament and uterus of mice results in altered collagen and matrix metalloproteinase activity. Biology of reproduction. Apr 2012;86(4):100
• Ma Y, MJ Zhu, AB Uthlaut, MJ Nijland, PW Nathanielsz, BW Hess, and SP Ford. Upregulation of growth signaling and nutrient transporters in cotyledons of early to midgestational nutrient restricted ewes. Placenta. 2011 Mar. 32(3): 255-63
• Ma Y, MJ Zhu, L Zhang, SM Hein, PW Nathanielsz, and SP Ford. Maternal obesity and overnutrition alters fetal growth rate and cotyledonary vascularity and angiogenic factor expression in the ewe. Am J Physiol Regul Integr Comp Physiol, 2010. 299(1): R249-58
• Zhu, MJ, Y Ma, W Hui, NM Long, M Du, and SP Ford. Maternal obesity increases placental fatty acid transporters of ewes at mid and late gestation. Am J Physiol Endocrinology and Metabolism. 2010 Nov; 299(5): R1224-31 (co-first author)
• Weems YS, Ma Y, Ford SP, et al. Effects of intraluteal implants of prostaglandin E1 or E2 on angiogenic growth factors in luteal tissue of Angus and Brahman cows. Theriogenology. Dec 2014;82(9):1224-1230.
• Zhang L, NM Long, SM Hein, Y Ma, PW Nathanielsz, and SP Ford. Maternal obesity in ewes results in reduced fetal pancreatic β-cell numbers in late gestation and decreased circulating insulin concentration at term. Domestic animal endocrinology. 2011; 40 (1): 30-39
• George LA, L Zhang, N Tuersunjiang, Y Ma, NM Long, AB Uthlaut, DT Smith, PW Nathanielsz, and SP Ford. Early maternal undernutrition programs increased feed intake, altered glucose metabolism and insulin secretion, and liver function in aged female offspring. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2012 April; 302 (7): R795-R804

Teaching

Current 

• Health Care Organization and Management